However, more in-depth studies are still needed to perform in different ethnicities in order to validate the associations between genetic polymorphisms in the CYP1A2 and CYP3A4 genes and breast cancer to reveal underlying molecular mechanism. This evidence concerns the gene CYP1A2 and breast carcinoma.